The happy destiny of frozen haematopoietic stem cells: from immature stem cells to mature applications.
Forty years ago, van Putten described in the European Journal of Cancer (see this issue) quantitative studies on the optimal storage techniques of mouse and monkey bone marrow suspensions. Survival of the animals after irradiation following injection with stored bone marrow cell suspensions was the endpoint. He observed some species differences, but based on the data obtained considered a careful trial of the glycerol-polyvinylpyrrolide (PVP) combination for storage of marrow in man was indicated. In spite of this, dimethyl sulphoxide has become the 'standard' cryopreservant for human marrow stem cells. Over the last 40 years, there has been a tremendous increase in knowledge about haematopoietic stem cells and their use in the clinic. Haematopoietic stem cells are now known to travel between the bone marrow and peripheral blood and are the best-characterised adult stem cells. These cells are currently widely used for transplantations in the clinic and are obtained from a wide variety of sources. These include the bone marrow, peripheral blood, cord blood, autologous as well as allogeneic stem cells from related or unrelated donors. Increasingly, data has become available that adult haematopoietic stem cells can generate differentiated cells belonging to other cell types, a process called "developmental plasticity". Thus, they may contribute to non-haematopoietic tissue repair in multiple organ systems. This has created a whole new potential therapeutic armamentarium for the application of haematopoietic stem cells outside of the area of malignancies and haematopoietic disorders.
de Vries
E G E
EG
Department of Medical Oncology, University Hospital Groningen, P.O. Box 30.001, Groningen, RB 9700, The Netherlands. e.g.e.de.vries@int.azg.nl
Vellenga
E
E
Kluin-Nelemans
J C
JC
Mulder
N H
NH
D000328:Adult; D000818:Animals; D001853:Bone Marrow; D015925:Cryopreservation / Q000379:methods; D005312:Fetal Blood; D000882:Haplorhini; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000628:therapy; D014021:Tissue Preservation / Q000379:methods; D014182:Transplantation, Autologous